NEWS
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Oscar krijgsman
Neogene Therapeutics - Leiden / Netherlands
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4982777
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Oscar krijgsman's MOST POPULAR ARTICLES
1-)
B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 11852020
2-)
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanomaCU Blank, EA Rozeman, LF Fanchi, K Sikorska, B van de Wiel, ...Nature medicine 24 (11), 1655-1661, 20186032018
3-)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanomaJ Müller, O Krijgsman, J Tsoi, L Robert, W Hugo, C Song, X Kong, ...Nature communications 5 (1), 5712, 20146002014
4-)
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2 …EA Rozeman, AM Menzies, ACJ van Akkooi, C Adhikari, C Bierman, ...The Lancet Oncology 20 (7), 948-960, 20194592019
5-)
Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastasesF Weeber, M Van De Wetering, M Hoogstraat, KK Dijkstra, O Krijgsman, ...Proceedings of the National Academy of Sciences 112 (43), 13308-13311, 20154542015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept